Aerie Pharmaceuticals, Inc. Gains 35.96%
Tue, Aug 23, 2022 at 07:02 PM
Aerie Pharmaceuticals, Inc. (AERI:NASDAQ) jumped higher at $15.16, a gain of 36%. On Tue, Aug 23, 2022, AERI:NASDAQ hit a New 2-Week High of $15.16. The stock appeared on our News Catalysts scanner on Tue, Aug 23, 2022 at 05:11 PM in the 'ACQUISITION' category. From Tue, Aug 09, 2022, the stock recorded 60.00% Up Days and 63.64% Green Days
About Aerie Pharmaceuticals, Inc. (AERI:NASDAQ)
Aerie Pharmaceuticals Inc is a clinical-stage pharmaceutical company. It is engaged in the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye.
Top 10 Gainers:
- Reviva Pharmaceuticals Holdings Inc. (RVPH:NASDAQ), 53.04%
- Neptune Wellness Solutions Inc. (NEPT:NASDAQ), 53%
- Indonesia Energy Corporation Limited (INDO:NYSEMKT), 49.35%
- Social Capital Suvretta Holdings Corp. I (DNAA:NASDAQ), 48.26%
- China Index Holdings Limited (CIH:NASDAQ), 42.86%
- Aerie Pharmaceuticals, Inc. (AERI:NASDAQ), 35.96%
- Nerdy Inc. Class A (NRDY:NYSE), 23.9%
- NLS Pharmaceutics Ltd. (NLSP:NASDAQ), 23.21%
- Secoo Holding Limited (SECO:NASDAQ), 23%
- Yield10 Bioscience, Inc. (YTEN:NASDAQ), 21.51%